In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Maiia SolovevaNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.
Maksim SolovevNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.ORCID 0000-0002-7944-6202 Igor YakutikNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.
Bella BidermanNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.ORCID 0000-0002-6253-3334 Elena NikulinaNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.
Natalya RisinskayaNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.ORCID 0000-0003-2957-1619 Tatiana ObukhovaNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.
Maria GladyshevaNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.ORCID 0000-0003-3337-2487 Alla KovriginaNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.ORCID 0000-0002-1082-8659 Yulia ChabaevaNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.ORCID 0000-0001-8044-598X Sergei KulikovNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.
Andrey SudarikovNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.ORCID 0000-0001-9463-9187 Larisa MendeleevaNational Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.
Funding
Russian Science Foundation (RSF) 25-25-20201
6 · The paper itselfAbstract
Multiple myeloma (MM) is a complex genetic disease characterized by the heterogeneity of tumor cells. We have measured
Indexed as
Circulating Tumor DNAMultiple MyelomaAdultAgedAged, 80 and overBiomarkers, TumorBone MarrowFemaleGTP PhosphohydrolasesHumansLiquid BiopsyMaleMembrane ProteinsMiddle AgedMutationPlasmacytomaBiomarkers, TumorBRAF protein, humanCirculating Tumor DNAGTP PhosphohydrolasesKRAS protein, humanMembrane ProteinsNRAS protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)array-CGHBRAFctDNAKRASliquid biopsymultiple myelomaNRASplasmacytoma
Identifiers
PMID40943426
PMCPMC12429773
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390